CryoLife Conducts Surgeons Cardiac Allograft...( ATLANTA April 24 /- CryoLife Inc....)

ATLANTA, April 24 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that it is conducting the 2008 Cardiac Allograft Symposium at its corporate headquarters training facility in suburban Atlanta, GA, April 25-26. The program will focus on current clinical outcomes, indications and surgical techniques of aortic valve replacement utilizing aortic allografts and the CryoValve(R) SG pulmonary human heart valves.

"As leaders in human tissue transplantation and cardiac reconstruction, it is both an honor and a privilege to host this advanced surgical training at our state-of-the-art facility and laboratory," said Steven G. Anderson, president and chief executive officer of CryoLife, Inc. "We look forward to bringing together this eminent group of cardiovascular surgeons and offering them the opportunity to learn the newest surgical techniques utilizing human aortic valves and our recently FDA-cleared CryoValve SG pulmonary valve."

The symposium's distinguished faculty includes: John W. Brown, M.D., professor of cardiothoracic surgery, Indiana University School of Medicine, Indianapolis, Ind; Paul E. Stelzer, M.D., senior faculty, cardiothoracic surgery, Mount Sinai School of Medicine, New York, N.Y.; Craig R. Saunders, M.D., chairman of cardiothoracic surgery, Saint Barnabas Health Care System, Newark, N.J.; Kent E. Ward, M.D., associate professor of pediatric cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, Okla; Kenton J. Zehr, M.D., professor of surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.; and Edward Nowicki, M.D., assistant head, clinical investigations, Heart & Vascular Institute, Cleveland Clinic, C
'/>"/>